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RESEARCH ARTICLE
Ovarian Masses: Is Multi-detector Computed Tomography a
Reliable Imaging Modality?
Yasir Jamil Khattak, Saima Hafeez, Tariq Alam, Madiha Beg*, Mohammad
Awais, Imrana Masroor
Abstract
Background: Ovarian cancer continues to pose a major challenge to physicians and radiologists. It is the
third most common gynecologic malignancy and estimated to be fifth leading cancer cause of death in women,
constituting 23% of all gynecological malignancies. Multi-detector computed tomography (MDCT) appears to
offer an excellent modality in diagnosing ovarian cancer based on combination of its availability, meticulous
technique, efficacy and familiarity of radiologists and physicians. The aim of this study was to compute sensitivity,
specificity, positive and negative predictive values and diagnostic accuracy of 64- slice MDCT in classifying
ovarian masses; 95% confidence intervals were reported. Materials and Methods: We prospectively designed
a cross-sectional analytical study to collect data from July 2010 to August 2011 from a tertiary care hospital in
Karachi, Pakistan. A sample of 105 women aged between 15-80 years referred for 64-MDCT of abdomen and
pelvis with clinical suspicion of malignant ovarian cancer, irrespective of stage of disease, were enrolled by nonprobability purposive sampling. All patients who were already known cases of histologically proven ovarian
carcinoma and having some contraindication to radiation or iodinated contrast media were excluded. Results:
Our prospective study reports sensitivity, specificity; positive and negative predictive values with 95%CI and
accuracy were computed. Kappa was calculated to report agreement among the two radiologists. For reader
A, MDCT was found to have 92% (0.83, 0.97) sensitivity and 86.7% (0.68, 0.96) specificity, while PPV and NPV
were 94.5% (0.86, 0.98) and 86.7% (0.63, 0.92), respectively. Accuracy reported by reader A was 90.5%. For
reader B, sensitivity, specificity, PPV and NPV were 94.6% (0.86, 0.98) 90% (0.72, 0.97) 96% (0.88, 0.99) and
87.1% (0.69, 0.95) respectively. Accuracy computed by reader B was 93.3%. Excellent agreement was found
between the two radiologists with a significant kappa value of 0.887. Conclusion: Based on our study results,
we conclude MDCT is a reliable imaging modality in diagnosis of ovarian masses accurately with insignificant
interobserver variability.
Keywords: Malignant - sensitivity and specificity - computed tomography - ultrasound - confidence intervals - Pakistan
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Introduction
Ovarian cancer continues to pose a major challenge
to physicians and radiologists. It is third most common
gynecologic malignancy (Silverberg et al., 1990; Tawani
et al., 2005) and estimated to be the fifth leading cancer
cause of death in women (Landis et al., 1998) after lung,
breast, colon, and pancreatic cancer and constitutes
23% of all gynecological malignancies (Woodward et
al., 2004). Nearly two thirds of all ovarian carcinomas
have progressed to disease stage III or IV at time of
first diagnosis because they may remain clinically
asymptomatic for extended periods (Nagell et al., 1990;
Kombacher et al., 1992). The “silent” nature of disease
and lack of established population-based screening
programmes are the major factors why the majority of
women present with advanced disease and consequently

have a poor prognosis. Seventy-six percent of patients
with ovarian cancer survive only 1 year after diagnosis
(Timpani et al., 2000).The incidence and mortality rates
of ovarian cancer increases with age and for all stages,
the 5-year survival rate is 45% (American Cancer Society,
2007).
Ovarian tumors are classified as epithelial tumors,
germ cell tumors, sex cord–stromal cell tumors, and
metastatic tumors on the basis of tumor origin (Koonings
et al., 1989).As most patients with ovarian carcinoma have
distant or widespread disease at the time of diagnosis,
this fact underscores the importance of early detection
and improved characterization of ovarian masses and is
of paramount and utmost importance in the preoperative
evaluation, enabling the surgeon to anticipate carcinoma
of the ovary before the operation, so that adequate
procedures are planned (Hermann et al., 1987; Mugel
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et al., 1993; Osmers et al., 1996; Sengupta et al., 2000).
Bimanual pelvic examination and serum CA-125 levels
have failed to allow consistent detection of ovarian
malignancy. Because the sensitivities of these techniques
are often below 50%, imaging modalities have become
indispensable (Jacobs et al., 1989; Taylor et al., 1994;
Kurtz et al., 1999; Ferozabadi et al., 2011). Sonography
has been shown to be a sensitive, but relatively nonspecific
method, leading to unnecessary surgical resection of many
benign lesions (Outwater et al., 1995). Besides clinical
examination, CA 125 levels, and ultrasonography, CT
scan is also used as a diagnostic technique for ovarian
carcinoma and is superior to US in assessment of the nature
of ovarian masses. It has proven as an excellent modality
in the diagnosis of women believed to have ovarian cancer
based on combination of its ready availability, meticulous
technique, efficacy and familiarity of radiologists and
physicians (Spencer et al., 2005). With the advent of 64slice multidetector Computed Tomography (MDCT), it
has become possible to acquire several thin slices and
image reconstruction in axial, coronal and sagittal planes
contributing valuable information towards preoperative
surgical and management planning (Parish, 2007).

Materials and Methods
A cross sectional analytical study was designed to
collect data from the Department of Radiology, Aga Khan
University Hospital Karachi from July 2010 to August
2011. Female patients (age range 15-80 years) referred
for 64-MDCT of Abdomen and pelvis with clinical
suspicion of malignant ovarian cancer irrespective of
stage of disease was included. Patients with signs and
symptoms of weight loss, abdominal or pelvic mass
detected on examination by physician deemed suspicious
for ovarian cancer were included in the study. Patients
who were already known case of histologically proven
ovarian carcinoma and, having some contraindication
to radiation or iodinated contrast media were excluded.
MDCT scan of abdomen and pelvis performed from dome
of the diaphragm to the pubic symphysis by 64 slice
Aquilion, Toshiba Medical System at 120 kvp and 350
mAs by a trained technologist with 5 years’ experience
in MDCT scanning. All patients received intravenous
non-ionic contrast medium omnipaque-300 (the dose of
which was decided according to age and weight of the
patient) and given by a computer-controlled injector at
rate of 4 ml/second. First, volume data with 0.5 mm slice
thickness were acquired in Porto-venous phase, followed
by multiplanar reconstruction in axial, coronal and sagittal
planes with a slice thickness of 5 mm each. MDCT
reporting regarding presence of carcinoma ovary was
done by consensus between two consultant radiologists
with 5 and 8 years’ clinical experience in women imaging.
Histopathological findings regarding malignancy were
obtained from medical/histopathology records of patients.
Data analysis procedure
Data were entered and analyzed by utilizing SPSS
windows package 19.0 version. Descriptive analysis was
conducted i.e. frequencies and percentages for categorical
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variables like malignant (positive for ovarian carcinoma)
or benign (negative for ovarian carcinoma) and mean and
standard deviation for the continuous variables like age.
Sensitivity and Specificity of 64-slice MDCT were
calculated and 95% Confidence Intervals (CI) reported.
Positive, negative predictive values and accuracy
were computed. The agreement between MDCT and
histopathological findings for ovarian carcinoma was
computed using kappa statistic between both readers.
Sample size calculation
Reported sensitivity of MDCT for the detection of
ovarian carcinoma is 90% (Jain, 1994; Jung et al., 2002)
taking confidence interval of 95%, bound on error of 6%,
the calculated sample size N=97. We enrolled 106 patients
in the study.
n=Z21-α/2-P(1-P)/B2

Results
During the study duration 105 women with a diagnosis
of ovarian mass (mean age 53.13±SD 9.7 years) were
enrolled in the study. Age range reported as 49 years,
minimum and maximum 33, and 82 respectively. Out of
105 ovarian lesions, 73 cases (69.5%) were read by First
radiologist as malignant and 32 (30.5%) as benign.
The second radiologist read 74 cases (70.5%)
as malignant and 31 (29.5%) as benign. On later
histopathological findings, 75 of 105 cases (71.4%) were
proven to be malignant while 30 (28.6%) turned out to be
benign.
Malignant lesions included Serous adenocarcinomas
(n=32), mucinous adenocarcinomas (n=24), endometrioid
carcinomas (n=12), malignant mullerian tumor (n=5)
and Granulosa cell tumors (n=2). Benign lesions were
endometriomas (n=15), benign cyst adenomas (n=5),
teratomas (n=5), dermoid (n=3), corpus luteal cysts (n=2),
simple ovarian cyst (n=1).
In case of the first radiologist, there were four false
positive cases: The first case on MDCT appeared as a
predominantly solid lesion with patchy areas of necrosis.
The interface with the adjacent fallopian tube was not
clear and appeared adherent to it. On histology this
mass proved to be degenerated subserosal fibroid. Since
there was minimal amount of ascites associated with
it as well, it was implicated as suspicious considering
the post menopausal status of the patient. Amongst the
other three patients two had multiple enhancing nodular
peritoneal deposits with pelvic adhesions secondary to
previous tuberculosis giving a bizarre appearance. One
of the patients had endometrioma deposit near the broad
ligament which was read as malignant. Three of these
cases were also read as malignant by the second reader as
well. All the four cases had associated mild to moderate
ascites as additional finding which further raised suspicion
for malignancy.
There were six false negatives in case of first
radiologist: Three of these cases were considered benign
on account of their small size, all less than 4 cm. Two
amongst these proved to be endometroid carcinoma.
Amongst these three cases, one was falsely negative by

Table 1. Radiologist A and B
64-MDCT
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Gold-standard (Histopathology)
Present (+ve) Absent (-ve)

Radiologist A:
Present (+ve) True positive (a)
69
False Positive (b)		
Absent (-ve) False Negative (c)
6
True Negative (d)		
Radiologist B:
Present (+ve) True positive (a)
71
False Positive (b)		
Absent (-ve) False Negative (c)
4
True Negative (d)		

4
26
3
27

the second radiologist. The remaining three false negative
cases were apparently simple cysts with internal septations
which all proved to be mucinous adenocarcinomas. Two
of these cases were read as negative for malignancy by the
second reader as well. Thus, for the first reader there were
69 true positives, 4 false positives, 26 true negative, and
6 false negative results. For the second reader there were
71 true positives, 3 false positives, 27 true negative, and 4
false negative results on MDCT based assessment. Overall
in case of first reader, MDCT was found to have 92%,
95%CI (0.83,0.97) sensitivity, 86.7%, 95%CI (0.68,0.96)
specificity, while PPV and NPV were 94.5%, 95%CI
(0.86,0.98) and 86.7%, 95%CI (0.63,0.92), respectively.
(Table 1; Radiologist B).
The sensitivity, specificity, PPV and NPV were 94.6%,
95%CI (0.86,0.98) 90%, 95%CI (0.72,0.97) 96%, 95%CI
(0.88,0.99) and 87.1%, 95%CI (0.69,0.95) respectively for
the second reader (Table 1; Radiologist B).
Kappa statistics for measure of agreement was
calculated between both readers for MDCT findings.
Excellent agreement was established between the two
radiologists with a significant kappa value of 0.887. Very
Good (k=0.771) and excellent (k=0.838) agreement was
also found between the MDCT and histopathological
findings for both readers with significant kappa values.

Discussion
Ovarian malignancy usually has a delayed presentation
due its non-specific symptoms. Most adnexal masses
are suspected when patients presents with complaint
of abdominal mass , or pain which later on is further
evaluated by ultrasonography. Once we come across a
neoplastic ovarian mass, it is imperative to decide whether
the mass is benign or malignant to determine further
treatment plan, and this is based largely on imaging
appearances in addition to laboratory findings (Buy et al.,
1991; Parkin et al., 2005)
The most commonly employed imaging modality for
pelvic pathologies and adnexal masses is ultrasonography.
Although it is the standard method for the preliminary
assessment, due to its low cost, easy availability and high
sensitivity of approximately 85-100%, it is still lagging
behind CT and MRI due to its variable specificity rate
(50-100%). On the other hand, the recent advances in CT
technology has allowed better detection and improved
role, not only in differentiation of benign and malignant

ovarian masses, but also evaluation of metastatic deposits
and extent of disease. Adequate determination of nature
of mass and disease extent proves useful in planning of
treatment which saves the patient unnecessary surgery and
expense (Tamai et al., 2006; Tsili et al., 2008).
The values of sensitivity and specificity of MDCT in
differentiation of ovarian masses are comparable to those
reported in literature (Kinkel et al., 2005; Tsili et al., 2008;
Gatreh-Samani et al., 2011). A sensitivity and specificity
of 81% and 87% has been reported by Kinkel et al. (2005)
in their Meta-analysis. Similarly Tsili et al. have reported
that MDCT can categorize adnexal masses into benign
and malignant with a sensitivity and specificity of up to
90.5% and 93.7% respectively. In our study, two separate
radiologists recorded the MDCT findings. Overall in case
of first reader, MDCT was found to have 92% sensitivity
and 86.68% specificity, while the second reader reported
a sensitivity and specificity 94.6%, 90% respectively. The
difference between the results of two radiologists was not
statistically significant. The relatively better results for
the second reader could be related to the difference of
experience between the two readers. Excellent agreement
was found between the findings reported by the two
readers and the histopathological results. Also, in our
study all patients underwent biopsy (Gold-standard),
thus minimizing verification bias and reporting accurate
sensitivity rate.
With the advancement in technology and availability
of MDCT with multiplanar reformation has resulted in
significantly improved characterization of adnexal masses.
One of the other advantages of MDCT is its fast
acquisition in addition to providing a detailed evaluation
of both adnexa and abdomen. The thin sections and high
resolution provides good details of internal architecture of
masses, leading to significantly improved characterization
of adnexal masses and a reliable differentiation between
benign and malignant ones. Moreover the near-isotropic
imaging possible with a 64 slice MDCT enabled
the acquisition of high resolution multiplanar and
3D-reconstructed images. These acquisitions added to the
detection of additional findings like ascites, invasion of
pelvic viscera and pathological lymph nodes which further
substantiated the confidence of readers in the diagnosis
of malignancy. The ability to perform these thin section
scans and reformatted images in different planes with
spatial resolution similar to the original scanning plane
has provided MDCT a pivotal role in staging and planning
of further surgical management.
There are myriad types of ovarian masses and
CT appearances vary widely. Accurate histologic
characterization is thus not always possible however some
tumors have certain radiologic features which predominate
and knowledge of these key findings may help in reaching
a specific diagnosis.
We in our study reported a diagnostic accuracy of
90.5% and 96% respectively by reader A and B. These
findings are comparable to those reported in literature
(Kinkel et al., 2005; Gatreh et al., 2011).There were
few false negative and false positive cases in this study.
The presence of ascites in a post-menopausal patient
with associated adnexal mass implicates possibility

Asian Pacific Journal of Cancer Prevention, Vol 14, 2013

2629

Yasir Jamil Khattak et al

of malignancy. The presence of these findings made
it difficult to exclude malignancy leading to false
positives. Cysts smaller than 4 cm containing smooth
non enhancing internal septations is a characteristic of
benign lesion, however few such cases turned out to be
mucinous adenocarcinomas on histopathology in our
study population. Previously studies (Tsili et al., 2008;
Adel et al., 2011; Satoh et al., 2011) have been carried
out on same topic; however no interobeserver agreement
was calculated.
This study had a few limitations as well. First, all
the patients sent for MDCT were included in the study
which could result in selection bias. Patient population
for ovarian lesions were relatively small.
In conclusion, based on our study we can conclude
that MDCT is a reliable imaging modality in diagnosis
of ovarian masses accurately and with insignificant
interobserver variability.
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